ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.676,41
1,61%
S&P 500
5.599,30
0,49%
Dow Jones
41.350,93
-0,20%
Euro vs US Dollar
1,08862
0,01%
Bitcoin
83.357,77
-0,38%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. PharmaCyte Biotech Inc (PMCB) Börsenkurse

PharmaCyte Biotech Inc

PharmaCyte Biotech Inc (PMCB)

NASDAQ
1,64
-0,12
(-6,82%)
Geschlossen 13 März 9:00PM
Verzögert um 15 Minuten
1,65
0,01
(0,61%)
Nach Börsenschluss: 10:50PM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
1,65
Gebot
1,44
Fragen
1,78
Volumen
32.942
1,47 Tagesbereich 1,76
1,39 52-Wochen-Bereich 2,58
Marktkapitalisierung
11,497M
Handelsende
1,76
Handelsbeginn
1,76
Letzte Trade
469
@
1.65
(formt)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 52.357
VWAP
1,5894
Durchschnittliches Volumen (3 Mio.)
18.273
Ausgegebene Aktien
6.968.134
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,65
Gewinn pro Aktie (EPS)
-2,47
Erlöse
-
Nettogewinn
-17,24M

Über PharmaCyte Biotech Inc

PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technol... PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Medicinal Chems,botanicl Pds
Website
ir.pharmacyte.com
Hauptsitz
Reno, Nevada, USA
Gegründet
2018
PharmaCyte Biotech Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PMCB. The last closing price for PharmaCyte Biotech was US$1,76. Over the last year, PharmaCyte Biotech shares have traded in a share price range of US$ 1,39 to US$ 2,58.

PharmaCyte Biotech currently has 6.968.134 shares in issue. The market capitalisation of PharmaCyte Biotech is US$12,26 million. PharmaCyte Biotech has a price to earnings ratio (PE ratio) of -0.65.

PMCB Neueste Nachrichten

Weitere Nachrichten

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
10 März 2025
PMCB (-6,82%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
10 März 2025
PMCB (-6,82%)

Form 8-K - Current report
Edgar (US Regulatory)
26 Februar 2025
PMCB (-6,82%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 Dezember 2024
PMCB (-6,82%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
04 Dezember 2024
PMCB (-6,82%)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Edgar (US Regulatory)
13 November 2024
PMCB (-6,82%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
13 August 2024
PMCB (-6,82%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.11-6.251.761.81991.6281481.78165509CS
40.053.1251.61.91.56206741.74183434CS
120.03642.255825483391.61361.91.45182731.66094927CS
26-0.1634-9.01069813611.81342.42291.45265291.77010227CS
52-0.33-16.66666666671.982.581.39242501.94627189CS
156-0.54-24.65753424662.193.231.39857542.34048278CS
260-1.43-46.42857142863.089.981.395950626.01350814CS

PMCB - Frequently Asked Questions (FAQ)

What is the current PharmaCyte Biotech share price?
The current share price of PharmaCyte Biotech is US$ 1,65
How many PharmaCyte Biotech shares are in issue?
PharmaCyte Biotech has 6.968.134 shares in issue
What is the market cap of PharmaCyte Biotech?
The market capitalisation of PharmaCyte Biotech is USD 12,26M
What is the 1 year trading range for PharmaCyte Biotech share price?
PharmaCyte Biotech has traded in the range of US$ 1,39 to US$ 2,58 during the past year
What is the PE ratio of PharmaCyte Biotech?
The price to earnings ratio of PharmaCyte Biotech is -0,65
What is the reporting currency for PharmaCyte Biotech?
PharmaCyte Biotech reports financial results in USD
What is the latest annual profit for PharmaCyte Biotech?
The latest annual profit of PharmaCyte Biotech is USD -17,24M
What is the registered address of PharmaCyte Biotech?
The registered address for PharmaCyte Biotech is 401 RYLAND ST STE 200-A, RENO, NEVADA, 89502
What is the PharmaCyte Biotech website address?
The website address for PharmaCyte Biotech is ir.pharmacyte.com
Which industry sector does PharmaCyte Biotech operate in?
PharmaCyte Biotech operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CRVOCervoMed Inc
US$ 6,15
(160,59%)
158,89M
ZENAZenaTech Inc
US$ 4,5505
(61,94%)
6,89M
OPRXOptimizeRx Corporation
US$ 6,265
(51,33%)
16,41M
SSPEW Scripps Company
US$ 2,05
(43,36%)
18,27M
GRPNGroupon Inc
US$ 13,9807
(43,10%)
11,17M
HITHealth In Tech Inc
US$ 1,32
(-82,31%)
16,73M
SPHLSpringview Holdings Ltd
US$ 1,24
(-79,33%)
10,7M
APDNApplied DNA Sciences Inc
US$ 0,0619
(-57,89%)
35,11M
ZYXIZynex Inc
US$ 3,39
(-51,57%)
3,82M
HEPAHepion Pharmaceuticals Inc
US$ 0,0488
(-41,90%)
79,16M
STISolidion Technology Inc
US$ 0,174899
(38,70%)
506,61M
NVDANVIDIA Corporation
US$ 115,74
(6,42%)
298,41M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,1432
(15,59%)
202,29M
VSTEVast Renewable Ltd
US$ 0,6182
(23,66%)
184,27M
CRVOCervoMed Inc
US$ 6,15
(160,59%)
154M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
PMCB
PharmaCyte Biotech
USOTC
SULMF
Sulliden Mining Capital (PK)
NASDAQ
EGAN
eGain
USOTC
VCVOF
Vinacapital Vietnam Oppo... (CE)
TG
A3L3LW
Telefonica Europe BV
USOTC
CUGCF
China Oriental (PK)
BIT
UB87PE
Unicredit Bank
BIT
WDIT27
Destination Italia
AMEX
WEIX
Dynamic Short Short Term...
USOTC
MWELF
MTI Wireless Edge (PK)
COIN
ACHUSD
Alchemy
USOTC
ATEAY
Atea ASA (PK)
USOTC
REAC
REAC (CE)
COIN
ACDGBP
Alliance Cargo Direct
ASE
SOFTWEB
SOFTWeb Adaptive IT Solu...
FX
SGDJPY
SGD vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten